Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent TaxesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Orix (ORXCF) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Orix (ORXCF) over the last 17 years, with Q4 2025 value amounting to $78.8 billion.

  • Orix's Total Non-Current Liabilities rose 292.41% to $78.8 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $78.8 billion, marking a year-over-year increase of 292.41%. This contributed to the annual value of $76.1 billion for FY2025, which is 257.74% down from last year.
  • As of Q4 2025, Orix's Total Non-Current Liabilities stood at $78.8 billion, which was up 292.41% from $80.5 billion recorded in Q3 2025.
  • In the past 5 years, Orix's Total Non-Current Liabilities ranged from a high of $87.8 billion in Q3 2021 and a low of $71.7 billion during Q4 2022
  • For the 5-year period, Orix's Total Non-Current Liabilities averaged around $79.1 billion, with its median value being $78.2 billion (2023).
  • As far as peak fluctuations go, Orix's Total Non-Current Liabilities surged by 1268.41% in 2021, and later tumbled by 1737.2% in 2022.
  • Orix's Total Non-Current Liabilities (Quarter) stood at $86.7 billion in 2021, then fell by 17.37% to $71.7 billion in 2022, then grew by 2.98% to $73.8 billion in 2023, then rose by 3.8% to $76.6 billion in 2024, then rose by 2.92% to $78.8 billion in 2025.
  • Its Total Non-Current Liabilities stands at $78.8 billion for Q4 2025, versus $80.5 billion for Q3 2025 and $80.9 billion for Q2 2025.